(Q43199661)

15 November 2017

title

Parkinson disease: Another player in gene therapy for Parkinson disease (English)

1 reference

15 November 2017

0 references

1 reference

Michael G Kaplitt

1

1 reference

15 November 2017

language of work or name

English

0 references

publication date

1 January 2010

1 reference

15 November 2017

published in

Nature Reviews Neurology

1 reference

15 November 2017

volume

6

1 reference

15 November 2017

issue

1

1 reference

15 November 2017

page(s)

7-8

1 reference

Dopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesia.

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.214

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.214

Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.214

Safety and tolerability of putaminal AADC gene therapy for Parkinson disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.214

Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.214

Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.214

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.214

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.214

Dyskinesia after fetal cell transplantation for parkinsonism: a PET study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.214

10.1038/NRNEUROL.2009.214

31 March 2020

Identifiers

DOI

1 reference

15 November 2017

1 reference